Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatlc hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies [1] (multiple letters)

M. G. Wyllie, Claus Roehrborn

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatlc hyperplasia: A pooled analysis of three double-blind, placebo-controlled studies [1] (multiple letters)'. Together they form a unique fingerprint.